Evidence map›Paper›PMID 34965102›Full record

ArticleInorganic chemistry2022

Chelating the Alpha Therapy Radionuclides

Aohan Hu, Victoria Brown, Samantha N MacMillan, Valery Radchenko, Hua Yang, Luke Wharton, Caterina F Ramogida, Justin J Wilson

Abstract read
In one paragraph

Article in Inorganic chemistry, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Stabilities of AcInorganic chemistry · 2026
    Article
  5. DFT calculation of AcScientific reports · 2026
    Article
  6. Preclinical characterization of 3p-C-DEPAEJNMMI radiopharmacy and chemistry · 2025
    Article
  7. Review
  8. Article
  9. Complexation of 3p-Heliyon · 2024
    Article
  10. Article
  11. Review
  12. Pharmaceutics · 2023
    Review
  13. Chelating Rare-Earth Metals (LnInorganic chemistry · 2022
    Article
  14. Advances in PSMA theranostics.Translational oncology · 2022
    Article
  15. HBioconjugate chemistry · 2022
    Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Aohan HuDepartment of Chemistry and Chemical Biology, Cornell University, Ithaca, New York 14853, United States.ORCID https://orcid.org/0000-0002-9720-3159
Victoria BrownDepartment of Chemistry, Simon Fraser University, Burnaby, British Columbia V5A 1S6, Canada.ORCID https://orcid.org/0000-0002-0216-3538
Samantha N MacMillanDepartment of Chemistry and Chemical Biology, Cornell University, Ithaca, New York 14853, United States.ORCID https://orcid.org/0000-0001-6516-1823
Valery RadchenkoLife Sciences Division, TRIUMF, Vancouver, British Columbia V6T 2A3, Canada.
Hua YangDepartment of Chemistry, Simon Fraser University, Burnaby, British Columbia V5A 1S6, Canada.ORCID https://orcid.org/0000-0003-1833-9515
Luke WhartonLife Sciences Division, TRIUMF, Vancouver, British Columbia V6T 2A3, Canada.ORCID https://orcid.org/0000-0002-0636-8741
Caterina F RamogidaDepartment of Chemistry, Simon Fraser University, Burnaby, British Columbia V5A 1S6, Canada.ORCID https://orcid.org/0000-0003-4815-2647
Justin J WilsonDepartment of Chemistry and Chemical Biology, Cornell University, Ithaca, New York 14853, United States.ORCID https://orcid.org/0000-0002-4086-7982

Funding

Chelation strategies for s-, p-, and f-block radionuclides for targeted alpha therapyR01EB029259 · NIBIB · CORNELL UNIVERSITY · PI WILSON, JUSTIN J · 2020 to 2023
$1.4M
Expanding the Therapeutic Potential of the Alpha Emitter Radium-223R21EB027282 · NIBIB · CORNELL UNIVERSITY · PI WILSON, JUSTIN J · 2019 to 2021
$619k
NIBIB NIH HHS R01 EB029259NIBIB NIH HHS R21 EB027282
6 · The paper itself

Abstract

The radionuclides

Indexed as

ActiniumBismuthChelating AgentsMacrocyclic CompoundsRadioisotopesAlpha ParticlesCoordination ComplexesHumansLigandsModels, MolecularMolecular StructureRadiopharmaceuticalsActiniumActinium-225BismuthBismuth-213Chelating AgentsCoordination ComplexesLigandsMacrocyclic CompoundsRadioisotopesRadiopharmaceuticals

Identifiers

PMID34965102
PMCPMC9372718

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.